Businesswire News Releases

May 21, 2024 10:30 ET
Iconic Brands Unite Under OMNI Retail Enterprises
In a monumental stride toward enhancing consumer experiences and choice, several esteemed e-commerce brands are unifying their presence under a new company, OMNI Retail Enterprises (OMNI). This partnership aims to redefine and reignite legacy retail brands while putting innovation at the forefront....
May 21, 2024 10:01 ET
P&G Professional Expands Laundry Care Lineup with Tide Professional Commercial Laundry Detergent and Downy Professional Fabric Softener, Providing Businesses with a Trusted Clean in One Wash
P&G Professional is expanding its laundry care lineup with Tide Professional Commercial Laundry Detergent and Downy Professional Fabric Softener. A recent SWNS survey1 revealed that the lack of cleanliness is the top reason respondents wouldn’t return to a busines...
May 21, 2024 10:00 ET
Arizona Cybersecurity Company Closes Third Acquisition Since 2022
Lumifi Cyber Inc. (Lumifi), a next-generation leader in the cybersecurity space, announces its acquisition of Netsurion, a 15-year-old Managed Extended Detection and Response (XDR) provider. The acquisition delivers enhanced security to Netsurion’s customer base through Lumifi’s U.S.-based Security Operations Center (SOC) alongside Lumifi’s proprietary SHIELDVision™ platform and is a milestone in Lumifi’s larger goal to disrupt the managed detection and response (MDR) space....
May 21, 2024 10:00 ET
May 21, 2024 10:00 ET
Edgewood Oncology Announces First Patients Dosed in Phase 2a Study of BTX-A51 in Genetically-Defined Breast Cancer
Edgewood Oncology, a clinical-stage biotechnology company focused on delivering BTX-A51 to patients with hematologic malignancies and genetically-defined solid tumors, today announced that the first two patients with metastatic breast cancer were treated with BTX-A51, a multi-specific kinase inhibitor of casein kinase 1 alpha (CK1α) and cyclin-dependent kinases 7 and 9 (CDK7 and CDK9), that synergistically targets master regulators of cancer. BTX-A51 is being evaluated in a Phase 2a study for the treatment of estrogen receptor positive / human epidermal growth factor receptor 2 negative (ER+/H...
May 21, 2024 10:00 ET
eGrowcery and CresLane Announce New Partnership to Optimize Grocery Retail
eGrowcery, a leading provider of white-label eCommerce platforms for the retail food industry, and CresLane Retail Solutions, renowned for its comprehensive POS systems, today announced a new partnership. This collaboration aims to equip supermarket retailers with advanced, shopper-centric ecommerce solutions that integrate seamlessly with in-person sales channels, enhancing the consumer shopping experience and improving operational efficiencies....
May 21, 2024 10:00 ET
Novata Announces New Investment to Expand Sustainability Solutions Globally
Novata, a certified B Corp with presence in the US, Europe, and Asia, today announced new financing from returning investors Hamilton Lane and S&P Global, and new investor Motive Ventures, which is backed by affiliates of Apollo Global Management (“Apollo”). The capital will fuel further enhancements of Novata’s sustainability solutions and will support innovat...
May 21, 2024 10:00 ET
Payoneer to Present at the William Blair Annual Growth Stock Conference
Payoneer Global Inc. (“Payoneer” or the “Company”) (NASDAQ: PAYO), the financial technology company empowering the world’s small and medium-sized businesses to transact, do business and grow globally, today announced that John Caplan, Chief Executive Officer, will present at William Blair’s 44th Annual Growth Stock Conference on Tuesday, June 4, 2024, at 9:40 AM ET....
May 21, 2024 10:00 ET
Related Group and W5 Group Open New Residential Concept in Wynwood, Miami’s First Ground-Up Co-Living Community; Curated, Fully Furnished Suites Starting in the $1,500s
Related Group, one of the country’s premier developers of sophisticated metropolitan living, and W5 Group, a leade...
May 21, 2024 09:28 ET
Investors Raise Concerns to Meta Regarding Child Safety on Social Media Platforms
Fiduciary Trust International, a global wealth manager and wholly-owned subsidiary of Franklin Templeton, announces that Meta shareholder Lisette Cooper, PhD, vice chair, has filed a resolution for shareholders to vote upon at Meta’s annual meeting in Menlo Park, CA on May 29, 2024....
May 21, 2024 09:00 ET
May 21, 2024 09:00 ET
IHI Appoints Susan Ehrlich, CEO of Zuckerberg San Francisco General, to its Board of Directors
The Institute for Healthcare Improvement (IHI) announced today that Susan Ehrlich, MD, MPP, has joined its
May 21, 2024 09:00 ET
May 21, 2024 09:00 ET
Leumit Health Services Expands Partnership with FeelBetter to Optimize Polypharmacy Patient Management and Drive Value-Based Care in Israel
FeelBetter, the leading provider of polypharmacy patient management technology and pioneer of Pharmaco-Clinical Intelligence, today announced that it has expanded its partnership with
May 21, 2024 09:00 ET
Level Access Receives Multiple Top Workplace Honors, Validating Investment in Inclusive Culture
Level Access, the leading provider of digital accessibility solutions, has received four prestigious workplace awards in the past several months, underscoring its commitment to creating an inclusive and supportive work environment. The awards recognize everything from work-life balance to engaging a remote-first culture and positive employee feedback....
May 21, 2024 09:00 ET
Numenta Unveils NuPIC 2.0, Elevates CPUs to Superior Choice for Running AI Models
Numenta Inc., the world leader in deploying large AI models on CPUs, announced version 2.0 of its flagship product, the Numenta Platform for Intelligent Computing (NuPIC™). NuPIC empowers companies to deploy large language models (LLMs) on CPUs, offering an efficient, scalable, and secure solution....
May 21, 2024 09:00 ET
PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (“PharmaCyte” or the “Company”), today announced a $7 million investment in MyMD Pharmaceuticals, Inc. (Nasdaq:MYMD) (“MyMD”) a clinical stage biopharmaceutical company committed to developing novel therapies for age-related diseases, autoimmune and inflammatory conditions. MyMD has announced positive data for a 40-patient Phase 2 clinical trial for its lead product, MYMD-1 in sarcopenia, and is moving its clinical program forward in consultation with the U.S. Food and Drug Administration (FDA). PharmaCyte’s investment in externally developed technology ...
May 21, 2024 09:00 ET
Relias Report Emphasizes Urgent Need for Improved Training and Resources in Maternal Health Care
Relias, the trusted education and workforce enablement partner to 12,000 healthcare and human services organizations and 4.5 million caregivers, today announced the release of its
May 21, 2024 09:00 ET
REQ, an Agital Company, Names Industry Veteran Elizabeth Shea as President
REQ, an Agital company after its acquisition in July 2023, today announced it has named Elizabeth Shea as president of REQ. Elizabeth came to...
May 21, 2024 09:00 ET
Syniverse, TalkingPoints Unite to Enhance Messaging Between Educators and Families
Syniverse, the world's most connected company®, has joined forces with TalkingPoints, an education technology nonprofit that improves student outcomes by facilitating effective partnerships between families and their children's schools. This collaboration prioritizes delivering critical SMS and MMS messages and boosts security by separating com...